首页 | 本学科首页   官方微博 | 高级检索  
     


Stereotactic body radiotherapy for liver tumors
Authors:PD Dr. Florian Sterzing  Thomas B. Brunner  Iris Ernst  Wolfgang W. Baus  Burkhard Greve  Klaus Herfarth  Matthias Guckenberger
Affiliation:1. Klinische Kooperationseinheit Strahlentherapie, Deutsches Krebsforschungszentrum (dkfz), INF 280, 69120, Heidelberg, Germany
2. Abteilung für Radioonkologie und Strahlentherapie, Radiologische Universit?tsklinik, Heidelberg, Germany
3. Klinik für Strahlenheilkunde, Radiologische Klinik, Universit?tsklinikum Freiburg, Freiburg, Germany
4. Klinik für Strahlentherapie – Radioonkologie, Universit?tsklinikum Münster, Münster, Germany
5. Klinik und Poliklinik für Strahlentherapie, Universit?tsklinikum K?ln, K?ln, Germany
6. Klinik für Radio-Onkologie, Universit?tsSpital Zürich, Zürich, Switzerland
Abstract:

Purpose

This report of the Working Group on Stereotactic Radiotherapy of the German Society of Radiation Oncology (DEGRO) aims to provide a practical guideline for safe and effective stereotactic body radiotherapy (SBRT) of liver tumors.

Methods

The literature on the clinical evidence of SBRT for both primary liver tumors and liver metastases was reviewed and analyzed focusing on both physical requirements and special biological characteristics.

Results

Recommendations were developed for patient selection, imaging, planning, treatment delivery, motion management, dose reporting, and follow-up. Radiation dose constraints to critical organs at risk are provided.

Conclusion

SBRT is a well-established treatment option for primary and secondary liver tumors associated with low morbidity.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号